StockStory.org on MSN4 小时
DexCom’s (NASDAQ:DXCM) Q4: Beats On RevenueMedical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results , with sales up 7.6% year on year to $1.11 billion.
I wouldn't be surprised if these products have fairy dust in them because the results are just magical. View Entire Post › ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果